Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
International Journal of Molecular Sciences|December 21, 2017
Role of Galectins in Multiple MyelomaPaola Storti, Valentina Marchica, Nicola GiulianiFrontiers in Immunology|August 4, 2025
Deciphering the bone marrow microenvironment's role in multiple myeloma immunotherapy resistanceNicolas Thomas Iannozzi, Nicola Giuliani, Paola StortiCancers|January 9, 2021
PD-L1/PD-1 Axis in Multiple Myeloma Microenvironment and a Possible Link with CD38-Mediated Immune-SuppressionFederica Costa, Valentina Marchica, Paola Storti, et al.Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|July 8, 2011
Angiogenesis and multiple myelomaNicola Giuliani, Paola Storti, Marina Bolzoni, et al.Frontiers in Immunology|November 14, 2024
Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patientsVincenzo Raimondi, Rosanna Vescovini, Mattia Dessena, et al.Expert Review of Hematology|March 3, 2018
Possible targets to treat myeloma-related osteoclastogenesisMarina Bolzoni, Denise Toscani, Paola Storti, et al.Frontiers in Oncology|October 31, 2022
Metabolic features of myeloma cells in the context of bone microenvironment: Implication for the pathophysiology and clinic of myeloma bone diseaseVincenzo Raimondi, Denise Toscani, Valentina Marchica, et al.Exploration of Targeted Anti-Tumor Therapy|September 8, 2022
A personalized molecular approach in multiple myeloma: the possible use of RAF/RAS/MEK/ERK and BCL-2 inhibitorsVincenzo Raimondi, Nicolas Thomas Iannozzi, Jessica Burroughs-Garcìa, et al.International Journal of Molecular Sciences|December 23, 2022
Molecular Features of the Mesenchymal and Osteoblastic Cells in Multiple MyelomaNicolas Thomas Iannozzi, Valentina Marchica, Denise Toscani, et al.Expert Review of Hematology|May 25, 2019
Novel targets for the treatment of relapsing multiple myelomaNicola Giuliani, Fabrizio Accardi, Valentina Marchica, et al.Pageof 5